Predictors of non-response to Hepatitis B vaccination in dialysis patients
Predictors of non-response to Hepatitis B vaccination in dialysis patients
Document number : 152741
Created by: Nicole Leather, 2014-06-27
Last revised by: Nicole Leather, 2015-09-03
Document created in: James Cook University

Not uppdated, final reminderNot uppdated, final reminder

1. Summary

Abstract for the general public

Due to the immunosuppression associated with uraemia, patients with end-stage renal disease have a reduced response to vaccination. The hepatitis B vaccine is routinely administered to all dialysis patients, however vaccine coverage is suboptimal. This study is aimed at determining predictors of non-seroconversion to the vaccine in this population.

Tutor

John Killen
Renal Unite, Cairns Private Hospital
Ronny Gunnarsson
Professor , James Cook University Australia and R&D unit for primary health care Sodra Alvsborg County Sweden

Workplaces involved in this project

information Added workplaces
Education - James Cook University (JCU) - Division of Tropical Health and Medicine - College of Medicine and Dentistry - Medicine - Cairns, Clinical School workplace verified by James Cook University on 2018-02-27
Health Care - Health care providers - Queensland Health - Cairns and Hinterland Hospital and Health Service - Cairns Hospital - Medicine - Renal services

3. Ethics and information for classification purposes

Waiver of the need for individual consent

A waiver of the need for individual consent is given by a HREC

Date commenced

2014-01-01

Predictors of non-response to Hepatitis B vaccination in dialysis patients, from James Cook University
http://au.researchweb.org/is/jcu/document/152741